BackgroundThe avian infectious bronchitis virus (IBV) remains a significant source of loss in the poultry industry and early diagnosis is required to prevent the disease from spreading. This study examined the combined use of an ELISA and Western blot (WB) to detect antibodies against the nucleocapsid protein (N) of IBV. The coding sequence for N was amplified by RT-PCR and expressed in Escherichia coli. A soluble recombinant N protein (rN) of approximately 50 kDa was obtained. A total of 389 sera were tested against the rN in ELISA and the results were compared with those of the commercial IDEXX IBV Ab test. ELISA-rN achieved a 90.34% sensitivity and 90.16% specificity. WB confirmed all false negative sera in ELISA-rN or IDEXX test as truly positive. The current study indicate that the combined use of rN in ELISA and WB is a powerful tool for the immunodiagnosis of avian infectious bronchitis.MethodsConstructed recombinant pAE/n expression vectors were used to transform E. coli BL21(DE3) Star competent cells (Invitrogen). The rN of infectious bronchitis virus was purified by affinity chromatography using HisTrap HP 1 mL columns pre-packed with pre-charged Ni Sepharose in the ÄKTAprime Automated Liquid Chromatography system (GE Healthcare). A total of 389 serum samples from chickens were used to develop and evaluate the ELISA-rN test. To standardize the indirect ELISA development, serum dilutions (1:100, 1:200 and 1:400) and different concentrations of purified rN antigen (50, 100 and 200 ng/well) were tested. Positive and negative sera for IBV were used as controls. The results were compared with those obtained from a commercial kit. Serum samples scored as negative with the commercial kit but as positive with the ELISA-rN were further analysed by Western blot analyses using the rN protein as an antigen. The results of the ELISA-rN were compared to the commercial kit results using receiver-operating characteristics curves, area under the curve, and confidence intervals with the software GraphPad Prism version 6.0 for Windows (GraphPad Software, USA).ResultsThe expected cDNA fragment of approximately 1240 bp was successfully amplified by PCR using primers designed to select for the coding region of the N protein. The rN was expressed as a soluble protein to avoid the refolding steps and, after purification a yield of 10 mg/L of rN was obtained. The SDS-PAGE results demonstrated the presence of two distinct bands that had a molecular mass of approximately 45 and 50 KDa. Out of 244 sera that scored positive in the commercial ELISA IDEXX IBV Ab Test, 220 were also positive in the ELISA-rN, yielding an ELISA-rN test sensitivity of 90.16%. Out of 145 sera that scored negative in the IDEXX IBV Ab Test, 131 also scored negative in the ELISA-rN, indicating a specificity of 90.34%. Sera that tested negative in the ELISA-rN and positive in the commercial test also reacted with the rN protein in Western blot.ConclusionsThe association between the ELISA and Western blot techniques developed in this study with a subunit of IBV...
Toxocariasis is a neglected zoonosis that affects children and adults. Recombinant proteins have been widely investigated for diagnosis, achieving high sensitivity and specificity in an overall population; however, little is known about age as a factor in its application. This study aims to investigate the diagnostic potential of Toxocara canis TES-30 and TES-120 recombinant proteins in humans, differentiating between its performance in children and adults. Serum samples collected from children and adults seropositive to Toxocara spp. were tested with indirect ELISA using T. canis TES-30 and TES-120 recombinant proteins produced in Escherichia coli. While rTES-30 sensitivity was not affected by age (81.8% in children and 87% in adults), rTES-120 sensitivity severely decreased in children to only 63.6%, down from 95.7% in adults. Furthermore, the sensitivity of rTES-30 increased to 97.8% after Western blotting confirmation. High specificity (>94%) against other geohelminths was reported for both recombinant proteins. Our study favors the use of rTES-30 with total IgG as the primary antibody in an indirect ELISA assay as a tool for epidemiological human studies.
BACKGROUNDThe B subunit of Escherichia coli heat-labile enterotoxin
(LTB) is a potent mucosal immune adjuvant. However, there is little
information about LTB's potential as a parenteral adjuvant.OBJECTIVESWe aimed at evaluating and better understanding rLTB's potential as a
parenteral adjuvant using the fused R1 repeat of Mycoplasma
hyopneumoniae P97 adhesin as an antigen to characterise the
humoral immune response induced by this construct and comparing it to that
generated when aluminium hydroxide is used as adjuvant instead.METHODSBALB/c mice were immunised intraperitoneally with either rLTBR1 or
recombinant R1 adsorbed onto aluminium hydroxide. The levels of systemic
anti-rR1 antibodies (total Ig, IgG1, IgG2a, and IgA) were assessed by
enzyme-linked immunosorbent assay (ELISA). The ratio of IgG1 and IgG2a was
used to characterise a Th1, Th2, or mixed Th1/Th2 immune response.FINDINGSWestern blot confirmed rR1, either alone or fused to LTB, remained antigenic;
anti-cholera toxin ELISA confirmed that LTB retained its activity when
expressed in a heterologous system. Mice immunised with the rLTBR1 fusion
protein produced approximately twice as much anti-rR1 immunoglobulins as
mice vaccinated with rR1 adsorbed onto aluminium hydroxide. Animals
vaccinated with either rLTBR1 or rR1 adsorbed onto aluminium hydroxide
presented a mixed Th1/Th2 immune response. We speculate this might be a
result of rR1 immune modulation rather than adjuvant modulation. Mice
immunised with rLTBR1 produced approximately 1.5-fold more serum IgA than
animals immunised with rR1 and aluminium hydroxide.MAIN CONCLUSIONSThe results suggest that rLTB is a more powerful parenteral adjuvant than
aluminium hydroxide when administered intraperitoneally as it induced higher
antibody titres. Therefore, we recommend that rLTB be considered an
alternative adjuvant, even if different administration routes are
employed.
Recombinant proteins are a suggested alternative for the diagnosis of toxocariasis. The current Escherichia coli recombinant protein overexpression system usually produces insoluble products. As an alternative, yeast such as Pichia pastoris have secretory mechanisms, which could diminish the cost and time for production. This study aimed to produce recombinant proteins in Pichia pastoris and verify their sensibility and specificity in an indirect ELISA assay. Two sequences (rTES-30 and rTES-120) of Toxocara canis excretory-secretory antigens were cloned in a pPICZαB vector and expressed in P. pastoris KM71H. Sera samples collected from human adults infected by Toxocara spp. were tested by indirect ELISA using rTES-30 and rTES-120 as antigens. Recombinant proteins were detected at 72 hours after induction, in the HIGHLIGHTS Pichia pastoris rTES evaluated as an alternative tool for toxocariasis diagnosis. No difference between sensitivities of glycosylated and partial glycosylated rTES. High-throughput expression and in vivo purification of rTES in Pichia pastoris. 2 Santos, L.M.; et al.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.